Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors
Authors:
- 14 September 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 6 (10) , 1080-1085
Abstract
Antibacterials with a novel mechanism of action offer a great opportunity to combat widespread antimicrobial resistance. Bacterial DNA Gyrase is a clinically validated target. Through physiochemical property optimization of a pyrazolopyridone hit, a novel class of GyrB inhibitors were discovered. Guided by structure-based drug design, indazole derivatives with excellent enzymatic and antibacterial activity as well as great animal efficacy were discovered.Keywords
This publication has 11 references indexed in Scilit:
- Prospects for Developing New Antibacterials Targeting Bacterial Type IIA TopoisomerasesCurrent Topics in Medicinal Chemistry, 2013
- Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial AgentsPLOS ONE, 2013
- Exploiting bacterial DNA gyrase as a drug target: current state and perspectivesApplied Microbiology and Biotechnology, 2011
- A New DNA Gyrase Inhibitor Subclass of the Cyclothialidine Family Based on a Bicyclic Dilactam−Lactone Scaffold. Synthesis and Antibacterial PropertiesJournal of Medicinal Chemistry, 2011
- Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyraseBioorganic & Medicinal Chemistry Letters, 2010
- 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IVBioorganic & Medicinal Chemistry Letters, 2009
- Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity RelationshipsJournal of Medicinal Chemistry, 2008
- Discovery and Development of ATPase Inhibitors of DNA Gyrase as Antibacterial AgentsCurrent Medicinal Chemistry, 2007
- Novel Inhibitors of DNA Gyrase: 3D Structure Based Biased Needle Screening, Hit Validation by Biophysical Methods, and 3D Guided Optimization. A Promising Alternative to Random ScreeningJournal of Medicinal Chemistry, 2000
- The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X‐ray crystallography.The EMBO Journal, 1996